As global healthcare changes, healthcare institutions are being tasked with handling a higher volume of patients, rising costs, and heightened performance pressures. Laboratories, in particular, are ...

Alinity, a family of next-generation clinical chemistry and immunoassay diagnostics from Abbott Laboratories (NYSE:ABT) is now being offered in Europe and other countries that distinguish the CE mark.

"Better healthcare begins with a high performing lab. Abbott's Alinity family is an unprecedented approach to providing a more efficient, complete lab solution that no competitor in the industry can ...

ABBOTT PARK, Ill., March 5, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that Regional Medical Laboratory, Inc. (RML) will use the company's most advanced technology, Alinity ci-series, to ...

How important are diagnostic tests in clinical decision making? Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge ...

* Abbott laboratories - ‍secured U.S. FDA 510 clearance for its alinity ci-series instruments for clinical chemistry and immunoassay diagnostics Source text for Eikon: Further company coverage: ...

AbbottABT has hit the headlines following the announcement of the receipt of CE Mark and commercial launch of Alinity h-series integrated system for hematology testing. Per management, the Alinity ...

North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, and Abbott announced that they signed a $252 million managed equipment services contract for the supply of all ...

NEXT GENERATION OF HARMONIZED SYSTEMS, COMBINED WITH RECENTLY LAUNCHED ALINIQ PROFESSIONAL SERVICES, PROVIDE A UNIQUE SOLUTION TO HELP LABS AND HOSPITAL SYSTEMS ACHIEVE MEASURABLY BETTER HEALTHCARE ...